Cargando…
Molecular Characterization of the Dual Effect of the GPER Agonist G-1 in Glioblastoma
Glioblastoma (GBM) is the most common primary brain tumor in adults. Despite conventional treatment, consisting of a chirurgical resection followed by concomitant radio–chemotherapy, the 5-year survival rate is less than 5%. Few risk factors are clearly identified, but women are 1.4-fold less affect...
Autores principales: | Hirtz, Alex, Bailly, Yann, Rech, Fabien, Pierson, Julien, Dumond, Hélène, Dubois-Pot-Schneider, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695951/ https://www.ncbi.nlm.nih.gov/pubmed/36430793 http://dx.doi.org/10.3390/ijms232214309 |
Ejemplares similares
-
GPER Agonist G-1 Disrupts Tubulin Dynamics and Potentiates Temozolomide to Impair Glioblastoma Cell Proliferation
por: Hirtz, Alex, et al.
Publicado: (2021) -
Astrocytoma: A Hormone-Sensitive Tumor?
por: Hirtz, Alex, et al.
Publicado: (2020) -
Identification of Gender- and Subtype-Specific Gene Expression Associated with Patient Survival in Low-Grade and Anaplastic Glioma in Connection with Steroid Signaling
por: Hirtz, Alex, et al.
Publicado: (2022) -
Effects of the selective GPER1 agonist G1 on bone growth
por: Iravani, Maryam, et al.
Publicado: (2019) -
Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist
por: Ding, Qingming, et al.
Publicado: (2022)